A unifying biology of sex steroid-induced apoptosis in prostate and breast cancers
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A unifying biology of sex steroid-induced apoptosis in prostate and breast cancers
Authors
Keywords
-
Journal
ENDOCRINE-RELATED CANCER
Volume 25, Issue 2, Pages R83-R113
Publisher
Bioscientifica
Online
2017-11-22
DOI
10.1530/erc-17-0416
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Participant-Reported Symptoms and Their Effect on Long-Term Adherence in the International Breast Cancer Intervention Study I (IBIS I)
- (2017) Samuel George Smith et al. JOURNAL OF CLINICAL ONCOLOGY
- Association Between Androgen Receptor Splice Variants and Prostate Cancer Resistance to Abiraterone and Enzalutamide
- (2017) Glenn J. Bubley et al. JOURNAL OF CLINICAL ONCOLOGY
- 20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years
- (2017) Hongchao Pan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer
- (2017) William U. Shipley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Direct detection of early-stage cancers using circulating tumor DNA
- (2017) Jillian Phallen et al. Science Translational Medicine
- Vaginal Estrogens and Aromatase Inhibitors
- (2017) Katherine Reeder-Hayes et al. JAMA Oncology
- Concerns About Methodology of a Trial Investigating Vaginal Health During Aromatase Inhibitor Therapy for Breast Cancer
- (2017) V. Craig Jordan JAMA Oncology
- Vaginal Testosterone Cream vs Estradiol Vaginal Ring for Vaginal Dryness or Decreased Libido in Women Receiving Aromatase Inhibitors for Early-Stage Breast Cancer
- (2017) Michelle E. Melisko et al. JAMA Oncology
- TRIM24 Is an Oncogenic Transcriptional Activator in Prostate Cancer
- (2016) Anna C. Groner et al. CANCER CELL
- Is There a Future for Chemoprevention of Prostate Cancer?
- (2016) M. C. Bosland Cancer Prevention Research
- Fibroblast growth factor receptor-1 protein expression is associated with prognosis in estrogen receptor-positive/human epidermal growth factor receptor-2-negative primary breast cancer
- (2016) Mai Tomiguchi et al. CANCER SCIENCE
- Tamoxifen resistance and metastasis of human breast cancer cells were mediated by the membrane-associated estrogen receptor ER-α36 signaling in vitro
- (2016) Wenwen Gu et al. CELL BIOLOGY AND TOXICOLOGY
- Whole Genomic Copy Number Alterations in Circulating Tumor Cells from Men with Abiraterone or Enzalutamide-Resistant Metastatic Castration-Resistant Prostate Cancer
- (2016) Santosh Gupta et al. CLINICAL CANCER RESEARCH
- Targeting the androgen receptor in triple-negative breast cancer
- (2016) Ayca Gucalp et al. CURRENT PROBLEMS IN CANCER
- Anti-Estrogen Withdrawal Effect With Raloxifene? A Case Report
- (2016) Walter Lemmo INTEGRATIVE CANCER THERAPIES
- Enzalutamide Versus Bicalutamide in Castration-Resistant Prostate Cancer: The STRIVE Trial
- (2016) David F. Penson et al. JOURNAL OF CLINICAL ONCOLOGY
- Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blind, phase 3 trial
- (2016) John F R Robertson et al. LANCET
- HSD3B1 and resistance to androgen-deprivation therapy in prostate cancer: a retrospective, multicohort study
- (2016) Jason W D Hearn et al. LANCET ONCOLOGY
- Minireview: The Link Between ERα Corepressors and Histone Deacetylases in Tamoxifen Resistance in Breast Cancer
- (2016) Stéphanie Légaré et al. MOLECULAR ENDOCRINOLOGY
- Treating cancer with selective CDK4/6 inhibitors
- (2016) Ben O'Leary et al. Nature Reviews Clinical Oncology
- AR aberrations and resistance to abiraterone or enzalutamide
- (2016) Gerhardt Attard et al. Nature Reviews Urology
- Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years
- (2016) Paul E. Goss et al. NEW ENGLAND JOURNAL OF MEDICINE
- Enhancing Endocrine Therapy Combination Strategies for the Treatment of Postmenopausal HR+/HER2– Advanced Breast Cancer
- (2016) Kathleen I. Pritchard et al. ONCOLOGIST
- Prior Adjuvant Tamoxifen Treatment in Breast Cancer Is Linked to Increased AIB1 and HER2 Expression in Metachronous Contralateral Breast Cancer
- (2016) Sara Alkner et al. PLoS One
- Clinician-Reported Barriers to Implementing Breast Cancer Chemoprevention in the UK: A Qualitative Investigation
- (2016) Samuel G. Smith et al. Public Health Genomics
- Combined treatment with everolimus and fulvestrant reversed anti-HER2 resistance in a patient with refractory advanced breast cancer: a case report
- (2016) Bing Sun et al. OncoTargets and Therapy
- Estrogen related receptor alpha in castration-resistant prostate cancer cells promotes tumor progression in bone
- (2016) Anais Fradet et al. Oncotarget
- Estrogen receptor alpha somatic mutations Y537S and D538G confer breast cancer endocrine resistance by stabilizing the activating function-2 binding conformation
- (2016) Sean W Fanning et al. eLife
- Differing Perspectives on Breast Cancer Chemoprevention
- (2016) V. Craig Jordan JAMA Oncology
- Intermittent Androgen Deprivation Therapy—An Important Treatment Option for Prostate Cancer
- (2016) Laurence Klotz et al. JAMA Oncology
- Differing Perspectives on Breast Cancer Chemoprevention
- (2016) Jack Cuzick et al. JAMA Oncology
- Statistical controversies in clinical research: long-term follow-up of clinical trials in cancer
- (2015) J. Cuzick ANNALS OF ONCOLOGY
- Proven value of translational research with appropriate animal models to advance breast cancer treatment and save lives: the tamoxifen tale
- (2015) V. Craig Jordan BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Cancer statistics, 2015
- (2015) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Loss of TGF Receptor Type 2 Expression Impairs Estrogen Response and Confers Tamoxifen Resistance
- (2015) S. Busch et al. CANCER RESEARCH
- Integrative Clinical Genomics of Advanced Prostate Cancer
- (2015) Dan Robinson et al. CELL
- AZD3514, an oral selective androgen receptor down-regulator in patients with castration-resistant prostate cancer – results of two parallel first-in-human phase I studies
- (2015) A. Omlin et al. INVESTIGATIONAL NEW DRUGS
- Selective Human Estrogen Receptor Partial Agonists (ShERPAs) for Tamoxifen-Resistant Breast Cancer
- (2015) Rui Xiong et al. JOURNAL OF MEDICINAL CHEMISTRY
- Estrogen Receptor Mutations Found in Breast Cancer Metastases Integrated With the Molecular Pharmacology of Selective ER Modulators
- (2015) V. Craig Jordan et al. JNCI-Journal of the National Cancer Institute
- Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials
- (2015) LANCET
- The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study
- (2015) Richard S Finn et al. LANCET ONCOLOGY
- Estrogen receptor alpha-36 (ER-α36): A new player in human breast cancer
- (2015) Zhao-Yi Wang et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Integration of Downstream Signals of Insulin-like Growth Factor-1 Receptor by Endoplasmic Reticulum Stress for Estrogen-Induced Growth or Apoptosis in Breast Cancer Cells
- (2015) P. Fan et al. MOLECULAR CANCER RESEARCH
- Palbociclib — Taking Breast-Cancer Cells Out of Gear
- (2015) Lisa A. Carey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Palbociclib in Hormone-Receptor–Positive Advanced Breast Cancer
- (2015) Nicholas C. Turner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of bipolar androgen therapy for asymptomatic men with castration-resistant prostate cancer: Results from a pilot clinical study
- (2015) M. T. Schweizer et al. Science Translational Medicine
- Estrogen and estrogen receptor alpha promotes malignancy and osteoblastic tumorigenesis in prostate cancer
- (2015) Sweta Mishra et al. Oncotarget
- Estrogen Receptor Mutations Found in Breast Cancer Metastases Integrated With the Molecular Pharmacology of Selective ER Modulators
- (2015) V. Craig Jordan et al. JNCI-Journal of the National Cancer Institute
- High Progesterone Receptor Expression in Prostate Cancer Is Associated with Clinical Failure
- (2015) Thea Grindstad et al. PLoS One
- Androgen receptor: structure, role in prostate cancer and drug discovery
- (2014) MH Eileen Tan et al. ACTA PHARMACOLOGICA SINICA
- PI3K-AKT-mTOR signaling in prostate cancer progression and androgen deprivation therapy resistance
- (2014) AndrewC Hsieh et al. ASIAN JOURNAL OF ANDROLOGY
- Tamoxifen through GPER upregulates aromatase expression: a novel mechanism sustaining tamoxifen-resistant breast cancer cell growth
- (2014) Stefania Catalano et al. BREAST CANCER RESEARCH AND TREATMENT
- Androgen metabolism in prostate cancer: from molecular mechanisms to clinical consequences
- (2014) K-H Chang et al. BRITISH JOURNAL OF CANCER
- Emergence of Constitutively Active Estrogen Receptor- Mutations in Pretreated Advanced Estrogen Receptor-Positive Breast Cancer
- (2014) R. Jeselsohn et al. CLINICAL CANCER RESEARCH
- Abiraterone Treatment in Castration-Resistant Prostate Cancer Selects for Progesterone Responsive Mutant Androgen Receptors
- (2014) E. J. Chen et al. CLINICAL CANCER RESEARCH
- The new biology of estrogen-induced apoptosis applied to treat and prevent breast cancer
- (2014) V Craig Jordan ENDOCRINE-RELATED CANCER
- Tamoxifen as the first targeted long-term adjuvant therapy for breast cancer
- (2014) V Craig Jordan ENDOCRINE-RELATED CANCER
- Identification of gene regulation patterns underlying both oestrogen- and tamoxifen-stimulated cell growth through global gene expression profiling in breast cancer cells
- (2014) Ping Fan et al. EUROPEAN JOURNAL OF CANCER
- A molecular model for the mechanism of acquired tamoxifen resistance in breast cancer
- (2014) Ping Fan et al. EUROPEAN JOURNAL OF CANCER
- Prostate cancer: Prognostic significance of the association of heterogeneous nuclear ribonucleoprotein K and androgen receptor expression
- (2014) PAOLA BARBORO et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Past, Present, and Future Challenges in Breast Cancer Treatment
- (2014) George W. Sledge et al. JOURNAL OF CLINICAL ONCOLOGY
- Linking Estrogen-Induced Apoptosis With Decreases in Mortality Following Long-term Adjuvant Tamoxifen Therapy
- (2014) V. C. Jordan JNCI-Journal of the National Cancer Institute
- Everolimus plus exemestane as first-line therapy in HR+, HER2− advanced breast cancer in BOLERO-2
- (2013) J. Thaddeus Beck et al. BREAST CANCER RESEARCH AND TREATMENT
- Glucocorticoid Receptor Confers Resistance to Antiandrogens by Bypassing Androgen Receptor Blockade
- (2013) Vivek K. Arora et al. CELL
- Inhibition of c-Src blocks oestrogen-induced apoptosis and restores oestrogen-stimulated growth in long-term oestrogen-deprived breast cancer cells
- (2013) Ping Fan et al. EUROPEAN JOURNAL OF CANCER
- Phase I Study of ARN-509, a Novel Antiandrogen, in the Treatment of Castration-Resistant Prostate Cancer
- (2013) Dana E. Rathkopf et al. JOURNAL OF CLINICAL ONCOLOGY
- ESR1 ligand-binding domain mutations in hormone-resistant breast cancer
- (2013) Weiyi Toy et al. NATURE GENETICS
- Activating ESR1 mutations in hormone-resistant metastatic breast cancer
- (2013) Dan R Robinson et al. NATURE GENETICS
- Germline BRCA1 mutations increase prostate cancer risk
- (2012) D Leongamornlert et al. BRITISH JOURNAL OF CANCER
- FoxA1 Specifies Unique Androgen and Glucocorticoid Receptor Binding Events in Prostate Cancer Cells
- (2012) B. Sahu et al. CANCER RESEARCH
- Modulating therapeutic effects of the c-Src inhibitor via oestrogen receptor and human epidermal growth factor receptor 2 in breast cancer cell lines
- (2012) Ping Fan et al. EUROPEAN JOURNAL OF CANCER
- The BOLERO-2 trial: the addition of everolimus to exemestane in the treatment of postmenopausal hormone receptor-positive advanced breast cancer
- (2012) Julia A Beaver et al. Future Oncology
- Cabozantinib in Patients With Advanced Prostate Cancer: Results of a Phase II Randomized Discontinuation Trial
- (2012) David C. Smith et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial
- (2012) Christina Davies et al. LANCET
- Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial
- (2012) Garnet L Anderson et al. LANCET ONCOLOGY
- Androgen receptor (AR) aberrations in castration-resistant prostate cancer
- (2012) Kati K. Waltering et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Phase I study of PD 0332991, a cyclin-dependent kinase inhibitor, administered in 3-week cycles (Schedule 2/1)
- (2011) G K Schwartz et al. BRITISH JOURNAL OF CANCER
- BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients
- (2011) Z Kote-Jarai et al. BRITISH JOURNAL OF CANCER
- Androgen deprivation therapy as adjuvant/neoadjuvant to radiotherapy for high-risk localised and locally advanced prostate cancer: recent developments
- (2011) H Payne et al. BRITISH JOURNAL OF CANCER
- Cell Autonomous Role of PTEN in Regulating Castration-Resistant Prostate Cancer Growth
- (2011) David J. Mulholland et al. CANCER CELL
- Intratumoral De Novo Steroid Synthesis Activates Androgen Receptor in Castration-Resistant Prostate Cancer and Is Upregulated by Treatment with CYP17A1 Inhibitors
- (2011) C. Cai et al. CANCER RESEARCH
- Androgen suppresses proliferation of castration-resistant LNCaP 104-R2 prostate cancer cells through androgen receptor, Skp2, and c-Myc
- (2011) Chih-Pin Chuu et al. CANCER SCIENCE
- Characterising the castration-resistant prostate cancer population: a systematic review
- (2011) M. Kirby et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Novel Membrane-associated Androgen Receptor Splice Variant Potentiates Proliferative and Survival Responses in Prostate Cancer Cells
- (2011) Xi Yang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Impact of Comorbidity on Survival Among Men With Localized Prostate Cancer
- (2011) Peter C. Albertsen et al. JOURNAL OF CLINICAL ONCOLOGY
- Unexpected Binding Orientation of Bulky-B-Ring Anti-Androgens and Implications for Future Drug Targets
- (2011) Charles B. Duke et al. JOURNAL OF MEDICINAL CHEMISTRY
- Incidence of Breast Cancer in the United States: Current and Future Trends
- (2011) W. F. Anderson et al. JNCI-Journal of the National Cancer Institute
- Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial
- (2011) Cornelis JH van de Velde et al. LANCET
- The Risks and Benefits of 5α-Reductase Inhibitors for Prostate-Cancer Prevention
- (2011) Marc R. Theoret et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abiraterone and Increased Survival in Metastatic Prostate Cancer
- (2011) Johann S. de Bono et al. NEW ENGLAND JOURNAL OF MEDICINE
- Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer
- (2011) José Baselga et al. NEW ENGLAND JOURNAL OF MEDICINE
- Estrogen induces apoptosis in estrogen deprivation-resistant breast cancer through stress responses as identified by global gene expression across time
- (2011) E. A. Ariazi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Opposing roles of ERα and ERβ in the genesis and progression of adenocarcinoma in the rat ventral prostate
- (2011) D.M.A. Attia et al. PROSTATE
- Implementation in a Large Health System of a Program to Identify Women at High Risk for Breast Cancer
- (2011) William L. Owens et al. Journal of Oncology Practice
- Regression of Castrate-Recurrent Prostate Cancer by a Small-Molecule Inhibitor of the Amino-Terminus Domain of the Androgen Receptor
- (2010) Raymond J. Andersen et al. CANCER CELL
- Integrative Genomic Profiling of Human Prostate Cancer
- (2010) Barry S. Taylor et al. CANCER CELL
- Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1–2 study
- (2010) Howard I Scher et al. LANCET
- Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
- (2010) Johann Sebastian de Bono et al. LANCET
- Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial
- (2010) Jack Cuzick et al. LANCET ONCOLOGY
- FKBP51 Promotes Assembly of the Hsp90 Chaperone Complex and Regulates Androgen Receptor Signaling in Prostate Cancer Cells
- (2010) L. Ni et al. MOLECULAR AND CELLULAR BIOLOGY
- Deconstructing the molecular portraits of breast cancer
- (2010) Aleix Prat et al. Molecular Oncology
- Lasofoxifene in Postmenopausal Women with Osteoporosis
- (2010) Steven R. Cummings et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bypass Mechanisms of the Androgen Receptor Pathway in Therapy-Resistant Prostate Cancer Cell Models
- (2010) Rute B. Marques et al. PLoS One
- Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor
- (2010) P. A. Watson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prolonged treatment with bicalutamide induces androgen receptor overexpression and androgen hypersensitivity
- (2010) Hiromitsu Kawata et al. PROSTATE
- NF-κB Regulates Androgen Receptor Expression and Prostate Cancer Growth
- (2009) Liying Zhang et al. AMERICAN JOURNAL OF PATHOLOGY
- Role of GPR30 in the mechanisms of tamoxifen resistance in breast cancer MCF-7 cells
- (2009) Atanas Ignatov et al. BREAST CANCER RESEARCH AND TREATMENT
- History of Aromatase: Saga of an Important Biological Mediator and Therapeutic Target
- (2009) R. J. Santen et al. ENDOCRINE REVIEWS
- Lower-Dose vs High-Dose Oral Estradiol Therapy of Hormone Receptor–Positive, Aromatase Inhibitor–Resistant Advanced Breast Cancer
- (2009) Matthew J. Ellis et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Outcomes of Localized Prostate Cancer Following Conservative Management
- (2009) Grace L. Lu-Yao JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen
- (2009) Mitch Dowsett et al. JOURNAL OF CLINICAL ONCOLOGY
- Redefining hormone resistance in prostate cancer
- (2009) Christopher J. Hoimes et al. Therapeutic Advances in Medical Oncology
- Splicing of a Novel Androgen Receptor Exon Generates a Constitutively Active Androgen Receptor that Mediates Prostate Cancer Therapy Resistance
- (2008) S. M. Dehm et al. CANCER RESEARCH
- Androgen Levels Increase by Intratumoral De novo Steroidogenesis during Progression of Castration-Resistant Prostate Cancer
- (2008) J. A. Locke et al. CANCER RESEARCH
- Rho/ROCK/actin signaling regulates membrane androgen receptor induced apoptosis in prostate cancer cells
- (2008) N PAPADOPOULOU et al. EXPERIMENTAL CELL RESEARCH
- mTOR inhibitors in the treatment of cancer
- (2008) Angelica Fasolo et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- The 38th David A. Karnofsky Lecture: The Paradoxical Actions of Estrogen in Breast Cancer—Survival or Death?
- (2008) V. Craig Jordan JOURNAL OF CLINICAL ONCOLOGY
- Molecular basis of agonicity and antagonicity in the androgen receptor studied by molecular dynamics simulations
- (2008) William H. Bisson et al. JOURNAL OF MOLECULAR GRAPHICS & MODELLING
- Membrane androgen receptor activation triggers down-regulation of PI-3K/AKT/NF-kapaB activity and induces apoptotic responses via BAD, FasL and cacpase 3 in DU145 prostate cancer cells.
- (2008) Natalia Papadopoulou et al. Molecular Cancer
- NFκB selectivity of estrogen receptor ligands revealed by comparative crystallographic analyses
- (2008) Kendall W Nettles et al. Nature Chemical Biology
- Estrogen signals via an extra-nuclear pathway involving IGF-1R and EGFR in tamoxifen-sensitive and -resistant breast cancer cells
- (2008) Richard J. Santen et al. STEROIDS
- Prolonged control of progressive castration-resistant metastatic prostate cancer with testosterone replacement therapy: the case for a prospective trial
- (2007) P. Mathew ANNALS OF ONCOLOGY
- Tamoxifen (ICI46,474) as a targeted therapy to treat and prevent breast cancer
- (2006) V Craig Jordan BRITISH JOURNAL OF PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started